Cabot (NYSE:CBT – Get Free Report) released its quarterly earnings data on Monday. The specialty chemicals company reported $1.67 earnings per share for the quarter, beating the consensus estimate of $1.66 by $0.01, FiscalAI reports. The company had revenue of $982.00 million for the quarter, compared to the consensus estimate of $943.16 million. Cabot had a return on equity of 20.37% and a net margin of 5.23%.Cabot’s revenue for the quarter was up 6.4% on a year-over-year basis. During the same quarter last year, the business posted $1.90 EPS. Cabot updated its FY 2026 guidance to 6.150-6.450 EPS.
Cabot Stock Down 0.7%
CBT traded down $0.56 during midday trading on Wednesday, hitting $81.40. The company had a trading volume of 163,953 shares, compared to its average volume of 477,960. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53. The company has a quick ratio of 0.96, a current ratio of 1.45 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $4.20 billion, a price-to-earnings ratio of 15.39, a PEG ratio of 11.63 and a beta of 0.84. The stock’s 50 day moving average price is $87.96 and its 200 day moving average price is $79.62.
Cabot Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be issued a $0.4725 dividend. This represents a $1.89 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date is Friday, August 28th. Cabot’s dividend payout ratio (DPR) is presently 35.73%.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
CBT has been the subject of several recent research reports. UBS Group upped their price objective on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Truist Financial set a $100.00 price objective on shares of Cabot in a research note on Wednesday. Mizuho increased their price objective on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Finally, JPMorgan Chase & Co. lifted their target price on Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a report on Wednesday, May 13th. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Cabot has an average rating of “Hold” and a consensus price target of $86.20.
Get Our Latest Stock Report on CBT
Cabot Company Profile
Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.
The company operates two primary segments: Reinforcement Materials and Performance Materials.
Further Reading
- Five stocks we like better than Cabot
- The FTC Is Suing Hims & Hers Health—Here’s Why Investors Shouldn’t Panic
- 3 Stocks Taking Very Different Routes Through the Summer Rally
- Is ADM’s Rally Getting Ahead of Its Policy Tailwind?
- CoreWeave Powers Up: The Asia Infrastructure Grab
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.
